Core Insights - The company is well positioned to compete and grow following the release of the CY 2026 Physician Fee Schedule by CMS, which is expected to bring stability and predictability to the market [1][2]. Company Strategy - The company has engaged with stakeholders to advocate for reforms in the Medicare reimbursement system for skin substitutes, aiming to reduce fraud, waste, and abuse in the industry [2]. - The final rule aligns with the proposals made in July, presenting a significant opportunity for the company due to its competitive advantages, including efficient operations, a proprietary commercial organization, advanced technology, a strong IP portfolio, and a solid balance sheet [3]. Market Outlook - The company plans to leverage its strengths to gain market share as the reimbursement environment evolves, while also prioritizing patient access to its proven technology [3]. - The company acknowledges the need for further improvements in the reimbursement system and will continue to advocate for these changes over time [3]. Company Overview - MiMedx is a leader in providing healing solutions, focusing on chronic and hard-to-heal wounds, with a vision to be the leading global provider through relentless innovation [6].

Core Insights - MiMedx Group, Inc. will report its operating and financial results for Q3 2025 on October 29, 2025, after market close [1] - A conference call and webcast will be held at 4:30 p.m. Eastern Time on the same day to discuss the results [1] Company Overview - MiMedx is a pioneer in healing solutions, focusing on chronic and hard-to-heal wounds with over a decade of experience [2] - The company aims to be the leading global provider of healing solutions through continuous innovation [2]

Company Overview - MiMedx Group, Inc. is a pioneer and leader in the healthcare sector focused on healing solutions, particularly for chronic and hard-to-heal wounds [2] - The company aims to be the leading global provider of healing solutions through relentless innovation to restore quality of life [2] Upcoming Investor Conferences - MiMedx will participate in the Craig-Hallum 22nd Annual Institutional Investor Conference on May 28, 2025, in Minneapolis, MN, with 1:1 sessions [1] - The company will also attend the Goldman Sachs 46th Annual Global Healthcare Conference on June 11, 2025, in Miami, FL, with 1:1 sessions [1] - Additionally, MiMedx will be part of the Northland Capital Growth Conference on June 25, 2025, which will be held virtually, also featuring 1:1 sessions [1]

Company Overview - MiMedx Group, Inc. is a pioneer in the healthcare sector, focusing on healing solutions for chronic and hard-to-heal wounds [3] - The company has over a decade of experience in providing products for wound care, burn, and surgical applications [3] - MiMedx aims to be the leading global provider of healing solutions through continuous innovation [3] Event Participation - MiMedx's senior management will participate in the BofA Securities 2025 Healthcare Conference in Las Vegas, NV [1] - The presentation is scheduled for May 13, 2025, at 5:15 p.m. PDT [2] - Investors interested in meeting with senior management can contact their Bank of America representative [2]